KNKhuen Foong Ng

Khuen Foong Ng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Khuen Foong Ng has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multiplex PCR in pediatric LRTIs: challenges and opportunities in LMICs

    by Jelitha Ramachanderam, Khuen F Ng, Chuin-Hen Liew, Kah K Tan

    Introduction: Lower respiratory tract infections (LRTIs) remain a leading cause of morbidity and mortality among children under five years of age, particularly in low- and middle- income countries (LMICs), where limitations in diagnostic capacity contribute to delayed and suboptimal clinical management. Conventional diagnostic methods are limited by slow turnaround time and reduced sensitivity, especially in mixed infections. This review synthesizes current evidence on the role of multiplex polymerase chain reaction (MxPCR) in the diagnosis and management of pediatric LRTIs, with emphasis on diagnostic accuracy, clinical impact, and implementation considerations in LMIC settings. Methodology: A narrative review of published literature was undertaken, focusing on studies evaluating MxPCR diagnostic performance, clinical outcomes, epidemiological insights, and cost-effectiveness in pediatric respiratory infections, with cross-reference to LMIC specific health system constraints. Observations: MxPCR consistently demonstrates high sensitivity and specificity for the detection of viral, bacterial, and mixed respiratory pathogens, enabling rapid and comprehensive pathogen identification. Evidence indicates improved antibiotic stewardship, reduced unnecessary investigations, and strengthened epidemiological surveillance. However, widespread adoption in LMICs remains limited by high per-test costs, infrastructure requirements, supply chain challenges, and limited local economic evaluation. Conclusions: MxPCR represents a valuable diagnostic advancement for pediatric LRTIs. Sustainable integration in LMICs will require context-specific cost-effectiveness studies, appropriate panel selection based on local epidemiology, and feasible funding. Until these conditions are met, selective use in tertiary or high-dependency pediatric settings, or case-by-case application based on severity, remains the most practical approach.

  • Open Access

    Current review of pediatric Fas-associated death domain protein deficiency: expanding clinical and therapeutic perspectives

    by Chuin-Hen Liew, Kah Kee Tan, Jelitha Ramachanderam, Sin Yee Teo, Khuen Foong Ng

    Fas-associated death domain protein (FADD) deficiency is a rare inborn error of immunity characterized by dysregulated T-cell proliferation. The clinical spectrum and management of FADD deficiency in children remain incompletely described. This review aimed to synthesize patient-level observational evidence on clinical manifestations, immunological and genetic findings, and treatment outcomes of pediatric patients with FADD deficiency. A literature search was conducted of PubMed, the Cochrane Library, and Scopus from database inception to July 2, 2026, and reference lists of eligible articles were reviewed. Inclusion criterion was articles on human clinical studies of patients with FADD gene mutation. Eligibility screening and data extraction were performed independently. Ten articles describing 18 patients were included. The reported ancestries included South Asian (n=9), European (n=6), and East/Central Asian (n=1). Parental consanguinity was reported in 10 of 12 patients (83.3%). Median age at onset was 0.8 years. Major presentations were fever-related encephalopathy, lymphoproliferation, and invasive pneumococcal disease. Common features included liver dysfunction, seizures, and functional hyposplenism. Regarding immunophenotyping, double-negative T cells were elevated in 9 of 10 patients (90%). Elevated soluble FAS ligand and interleukin-10 levels and defective lymphocyte apoptosis were observed in all tested patients; most patients had elevated vitamin B12 levels. The most common pathogenic variant was c.350G>A, followed by c.315T>G. Six patients died (33%) at a median age of 0.8 years. Mortality was high among patients with invasive pneumococcal disease; no deaths were reported among those with a lymphoproliferative phenotype or among the 2 hematopoietic stem cell transplantation recipients. FADD deficiency ranges from early-onset fever-related encephalopathy and fulminant sepsis to lymphoproliferative phenotypes. This review emphasizes the importance of recognizing FADD deficiency in children presenting with recurrent febrile encephalopathy, liver dysfunction, and a history of consanguinity and highlights prompt genetic evaluation and hematopoietic stem cell transplantation as potential curative therapies.

  • Remdesivir and Nitazoxanide for Chronic Norovirus Type 1 Infection in a Child Post-cardiac Transplantation

    by Fabian J. S. van der Velden, Clive Graham, Glyn Jones, Khuen Foong Ng, Zdenka Reinhardt, Shirelle Burton-Fanning, Judith Breuer, Marieke Emonts

  • Open Access

    Treosulfan–fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study

    by Su Han Lum, Sinéad Greener, Irum Latif Memon, Persis Amrolia, Zohreh Nademi, Robert Chiesa, Juliana Silva, Helen Young, Stephen Owens, Eleri Williams, et al.

    Summary: Allogeneic haematopoietic stem cell transplantation (HSCT) is a curative therapy for severe combined immunodeficiency (SCID). Conditioning improves donor engraftment and freedom from immunoglobulin replacement (IgR) but increases the risks of acute and late toxicity. Treosulfan, a reduced toxicity alkylating agent, has emerged as an alternative to busulfan. In this UK multicentre study, we evaluated outcomes of 104 infants with SCID who underwent first HSCT following treosulfan‐fludarabine conditioning between 2006 and 2022. After a median follow‐up of 5.4 years, 5‐year overall survival (OS) and event‐free survivals (EFS) were 81% and 77% respectively. On multivariate analysis, molecularly undefined SCID (OS hazard ratio [HR] 5.61; EFS HR 5.55) and pre‐HSCT cytomegalovirus (CMV) infection (OS HR 3.94; EFS 3.68) were independently associated with inferior OS and EFS; RAG‐DCLRE1C genotypes also predicted worse EFS (HR 4.35). Cumulative incidence of endothelial cell dysfunction (ECD) was 11%. Treosulfan dose was not associated with OS, EFS, ECD or donor myeloid chimerism. Low mixed donor myeloid chimerism was observed across all treosulfan doses, but IgR freedom was achieved in 92% of survivors after first HSCT. Treosulfan‐fludarabine provides excellent survival with low endothelial toxicity for SCID HSCT, with potential for optimisation via pharmacokinetic guided dosing.

  • Open Access

    Human Adenovirus Respiratory Infection among Hospitalized Children in Seremban, Malaysia

    by Zhen Yun Siew, Isaac Seow, Zhen Ji Lai, Hui Chee Tier, Seck How Ho, Yeh Fong Tan, Khuen Foong Ng, Ming Lee Lee, Kah Kee Tan, SIewTung Wong, et al.

    This study aims to isolate clinical adenovirus among hospitalized children in Seremban, Malaysia. After that, determination of the serotype and genetic relatedness of isolated adenovirus through phylogenetic analysis with the published database of human adenovirus from GenBank will be carried out. 26 HAdV-positive retrospective respiratory specimens were collected from pediatric patients with respiratory distress at the Pediatric Department of Hospital Tuanku Jaafar in Seremban, Malaysia. HAdV was isolated in A549 cell culture, sequenced and analysed for HAdV typing. Based on hexon, penton, DNA polymerase, fiber, and virus-associated (VA) RNAII genes, there were 22/26 samples (84.62%) and 3/26 samples (11.54%) belonging to serotypes 7 and 3, respectively. Also, 1/26 sample (3.85%) was determined as HAdV subgroup D. In short, this study serves as a continuation to monitor the prevalence of HAdV serotypes in Malaysia and our result shows HAdV B as the most predominant circulating group of HAdV in Malaysia between 2013 – 2017.

  • Interpretation: use of autoantibodies in children

    by Hayley King, Antonis Tofias, Abbie Greenhill, Aidan Grimes, Khuen Foong Ng

    Judicious use of autoantibodies in paediatrics can be challenging. Autoimmune conditions can present with a wide range of signs and symptoms, many of which are non-specific. In combination with clinical features and laboratory findings, autoantibodies can facilitate diagnosis and in certain cases inform prognosis. Evidence for use of autoantibodies to guide and monitor treatment is limited. Caution is necessary when interpreting adult studies. We summarise the use of autoantibodies in paediatric practice with a guide on how they may be used.


  • Is it safe for neonates with probable bacterial infection to be treated with oral antibiotics in high-income countries?

    by Alison Gifford, Eva Louise Wooding, Khuen Foong Ng

    In the setting of high-income countries (HIC), is it safe to switch intravenous antibiotics to the oral route in term neonates with culture-negative early-onset infection (EOI) who are clinically improving and tolerating oral feeds?


  • Open Access

    The Multifaceted Syndromic Primary Immunodeficiencies in Children

    by Khuen Foong Ng, Anu Goenka, Florence Manyika, Jolanta Bernatoniene

    Background: Disorders of immunity are poorly recognised in some rare multisystem genetic conditions. We aim to describe syndromic features and immunological defects in children with syndromic primary immunodeficiencies (sPIDs). Methods: This is a retrospective descriptive study of children aged 0–18 years with sPIDs under the care of the paediatric immunology service at the Bristol Royal Hospital for Children, United Kingdom, from January 2006 to September 2021. Results: sPIDs were identified in 36 patients. Genetic diagnoses which are not commonly associated with PIDs and not included in the International Union of Immunological Societies classification were present in 7/36 (19%): Trisomy 22, Arboleda-Tham syndrome, 2p16.3 deletion syndrome, supernumerary ring chromosome 20 syndrome, Myhre syndrome, Noonan syndrome, and trichothiodystrophy/Cockayne syndrome complex. Recurrent and/or severe infections were the most common clinical features (n = 33, 92%). Approximately half had combined immunodeficiency or antibody deficiency. The most common extra-immunological manifestations include dysmorphism (72%), disorders of nervous (78%), musculoskeletal (69%), haematology/lymphatic (58%), and gastrointestinal, hepatic/pancreatic (58%) systems. Conclusions: Patients with sPIDs often have multiorgan involvement and some are non-immunologically mediated. There should be a low threshold to clinically assess and investigate for disorders of immunity in any patients with syndromic features especially when they present with recurrent/severe/opportunistic infections, features of immune dysregulation, autoinflammation or lymphoproliferation.


  • Open Access

    The Multifaceted Syndromic Primary Immunodeficiencies in Children

    by Khuen Foong Ng, Anu Goenka, Florence Manyika, Jolanta Bernatoniene

    Background: Disorders of immunity are poorly recognised in some rare multisystem genetic con-ditions. We aim to describe syndromic features and immunological defects in children with syn-dromic primary immunodeficiencies (sPIDs). Methods: This is a retrospective descriptive study of children aged 0-18 years with sPIDs under the care of the paediatric immunology service at the Bristol Royal Hospital for Children, United Kingdom from January 2006 to September 2021. Results: sPIDs were identified in 36 patients. Genetic diagnoses which are not commonly associ-ated with PIDs and not included in the International Union of Immunological Societies classifica-tion were present in 7/36 (19%): Trisomy 22, Arboleda-Tham syndrome, 2p16.3 deletion syn-drome, supernumerary ring chromosome 20 syndrome, Myhre syndrome, Noonan syndrome, trichothiodystrophy/Cockayne syndrome complex. Recurrent and/or severe infections were the commonest clinical features (n=33, 92%). Approximately half had combined immunodeficiency or antibody deficiency. Commonest extra-immunological manifestations include dysmorphism (72%), disorders of nervous (78%), musculoskeletal (69%), haematology/lymphatic (58%), and gastrointestinal, hepatic/pancreatic (58%) systems. Conclusions: Patients with sPIDs often have multiorgan involvement and some are non-immunologically mediated. There should be low threshold to clinically assess and investi-gate for disorders of immunity in any patients with syndromic features especially when they pre-sent with recurrent/severe/opportunistic infections, features of immune dysregulation, autoin-flammation or lymphoproliferation.


  • Remember the heart: neonatal myocarditis

    by Khuen Foong Ng, Jack Gibb, Siske Struik, Peter J Davis, Peter Muir, Chris Gillett, Sivakumar Oruganti, Marion Roderick